AI assistant
Fulgent Genetics, Inc. — Director's Dealing 2019
Mar 8, 2019
32553_dirs_2019-03-07_c0f32251-06ce-44f5-ba61-9c1f6aea3903.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Fulgent Genetics, Inc. (FLGT)
CIK: 0001674930
Period of Report: 2019-03-05
Reporting Person: Hsieh Ming (Director, President and CEO, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-03-05 | Common Stock | P | 8739 | $4.9479 | Acquired | 6579326 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1315789 | Indirect |
Footnotes
F1: The shares were purchased in multiple transactions at prices ranging from $4.85 to $4.95, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F2: The securities are held of record by the Ming Hsieh Annuity Trust established May 4, 2016, over which the reporting person possesses sole voting and dispositive power as the sole trustee.